Home » Stocks » HSIC

Henry Schein, Inc. (HSIC)

Stock Price: $65.01 USD -0.61 (-0.93%)
Updated Feb 24, 2021 4:00 PM EST - Market closed
Market Cap 9.26B
Revenue (ttm) 10.12B
Net Income (ttm) 403.79M
Shares Out 142.50M
EPS (ttm) 2.82
PE Ratio 23.08
Forward PE 17.09
Dividend n/a
Dividend Yield n/a
Trading Day February 24
Last Price $65.01
Previous Close $65.62
Change ($) -0.61
Change (%) -0.93%
Day's Open 65.18
Day's Range 64.90 - 66.66
Day's Volume 1,174,599
52-Week Range 41.85 - 74.89

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Forbes - 17 hours ago

We think that ​Henry Schein currently is a better pick compared to Boston Scientific. HSIC stock trades at about 0.9x trailing Revenues, compared to around 5.5x for Boston Scientific.

Other stocks mentioned: BSX
Business Wire - 1 day ago

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. has been recognized by Ethisphere as one of the 2021 World's Most Ethical Companies.

Business Wire - 2 days ago

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. announced that it will virtually present at the 2021 Barclays Global Healthcare Conference on March 9, 2021.

Business Wire - 6 days ago

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers in the Southern, Mid-Atlantic, and Northeastern states that the Henry Schein Customer Assistance Hotlin...

Zacks Investment Research - 6 days ago

The dental equipment market seems ready to grow as it continues to recover from the COVID-19 pandemic slump, making it prudent to look at names like Henry Schein (HSIC) and McKesson (MCK)

Other stocks mentioned: ALGN, BDX, MCK
Zacks Investment Research - 1 week ago

Henry Schein (HSIC) sees robust segmental performance in Q4 boosted by strong rebound in sales, and solid demand for PPE and COVID-19-related products.

CNBC Television - 1 week ago

Henry Schein CEO on how to make the U.S. vaccine rollout more efficient

Medical supply distributor Henry Schein has a unique view on the pandemic and the recovery. Henry Schein CEO Stanley Bergman joined "Squawk Box" on Wednesday to give his insight on the vaccine...

Zacks Investment Research - 1 week ago

Henry Schein (HSIC) delivered earnings and revenue surprises of 4.17% and 10.70%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 1 week ago

Shares of Henry Schein (NASDAQ:HSIC) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share were up 3.09% year over year to $1.00, which beat the estimate o...

Business Wire - 1 week ago

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. reports fourth quarter 2020 financial results from continuing operations.

Zacks Investment Research - 1 week ago

Henry Schein (HSIC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Investment Research - 2 weeks ago

Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 2 weeks ago

Henry Schein's (HSIC) medical business' PPE sales are likely to have maintained its momentum along with global recovery trends of the dental business during Q4.

Business Wire - 2 weeks ago

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. announced that Mohamad Ali and Deborah Derby have been appointed as members of the Company's Board of Directors.

Business Wire - 3 weeks ago

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. to webcast fourth quarter and full-year 2020 conference call on Wednesday, February 17, 2021.

Business Wire - 3 weeks ago

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. has been named to the FORTUNE® “World's Most Admired Companies” list for 2021, the 20th consecutive year it has been so honored.

Business Wire - 3 weeks ago

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Earns Top Marks In Human Rights Campaign's 2021 Corporate Equality Index

Zacks Investment Research - 1 month ago

Here are some dirt-cheap MedTech value stocks which are expected to provide long-term gains in 2021.

Other stocks mentioned: DGX, FMS, IVC
Zacks Investment Research - 1 month ago

The developments are expected to strengthen Henry Schein's (HSIC) presence in high potential and still-untapped markets.

Business Wire - 1 month ago

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. acquires majority interest in Prism Medical Products and enters the home medical supply market.

Business Wire - 1 month ago

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. completes joint venture with Casa Schmidt to offer an expanded array of products and services to customers in Spain and Portugal.

InvestorPlace - 1 month ago

As the Covid-19 pandemic worsens, the case for dental stocks to buy might not seem too bright. However, this sector is a very broad one, with upside opportunities available right now.

Other stocks mentioned: CL, CVS, GSK, JNJ, MMM, PG, XRAY
Business Wire - 2 months ago

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. will virtually present at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021, at 7:30 a.m. Eastern time.

Business Wire - 2 months ago

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Medical, the U.S. Medical business of Henry Schein, Inc., today announced the availability of Ansell Healthcare Product's AlphaTec® Model 214 gown...

Business Wire - 2 months ago

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Medical, the U.S. medical business of Henry Schein, Inc., recently entered into a distribution agreement with Yosi Health, a provider of digital p...

Business Wire - 2 months ago

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. will open the Nasdaq Stock Market in commemoration of its 25th anniversary as a publicly traded company.

Zacks Investment Research - 2 months ago

Is Henry Schein (HSIC) a great pick from the value investor's perspective right now? Read on to know more.

InvestorPlace - 2 months ago

More households own pets than have children, and they'll pay to keep their furry friends happy. Here are 6 big pet stocks.

Other stocks mentioned: CVET, FDS, MRK, NSRGY, ZTS
Zacks Investment Research - 2 months ago

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?

Business Wire - 2 months ago

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Announces Virtual Presence at Greater New York Focused on 3D Imaging, 3D Printing, and CAD/CAM Solutions

Seeking Alpha - 3 months ago

Henry Schein has had a period of sequential growth, fuelled entirely by Covid-related demand and PPE distribution. Covid exposure is an interesting factor for the company, presenting near-term...

Business Wire - 3 months ago

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. announced that the Company will present at several virtual investor conferences in December.

Business Wire - 3 months ago

CALGARY, Alberta--(BUSINESS WIRE)-- #albertadentist--With businesses everywhere struggling to keep their doors open, one small firm has big reasons to celebrate. Stream Dental Staffing Solutio...

Seeking Alpha - 3 months ago

Henry Schein, Inc.'s (HSIC) CEO Stanley Bergman on Q3 2020 Results - Earnings Call Transcript

Seeking Alpha - 3 months ago

Henry Schein, Inc. (HSIC) CEO Stanley Bergman on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 3 months ago

Henry Schein (HSIC) sees robust segmental performance in Q3 boosted by strong rebound in sales and solid demand for PPE and COVID-19-related products.

Zacks Investment Research - 3 months ago

Henry Schein (HSIC) delivered earnings and revenue surprises of 43.06% and 16.55%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Business Wire - 3 months ago

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. reported record third quarter 2020 financial results from continuing operations.

Zacks Investment Research - 3 months ago

Several medical product stocks have come up with bullish earnings reports so far this reporting cycle. Let's see how STE, HSIC, PACB, INSP are poised ahead of their announcements.

Other stocks mentioned: INSP, PACB, STE
Zacks Investment Research - 3 months ago

Henry Schein (HSIC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Investment Research - 3 months ago

3 Dental Supplies Stocks Set to Shine on the Industry's Upturn

Other stocks mentioned: ABC, ALGN, BDX, CAH, COO, LH, MCK, PDCO, WST, XRAY
Business Wire - 3 months ago

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. today announced its exclusive distribution agreement with Carrizo Dental, a leading Córdoba-based distributor of dental supplies and equipme...

Zacks Investment Research - 3 months ago

Henry Schein's (HSIC) medical business' PPE sales are likely to have maintained its momentum along with global recovery trends of the dental business during Q3.

Business Wire - 3 months ago

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein announces participation in upcoming virtual conferences in November.

Zacks Investment Research - 3 months ago

Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 3 months ago

MELVILLE, N.Y.--(BUSINESS WIRE)--TDSC.com, Powered by Henry Schein is live and will continue to offer members with an everyday low-price, online option for obtaining dental supplies.

Business Wire - 4 months ago

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. will release its third quarter 2020 financial results before the stock market opens on Monday, November 2, 2020.

Business Wire - 5 months ago

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) announced today that it has been named to FORTUNE® magazine’s "Change the World" list, an annual ranking of companies that ha...

Business Wire - 5 months ago

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc.

Zacks Investment Research - 5 months ago

Henry Schien's (HSIC) customer base is likely to benefit from the Teledent platform.

About HSIC

Henry Schein, a solutions company for health care professionals, provides health care products and services to office-based dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth,... [Read more...]

Industry
Medical Distribution
IPO Date
Nov 3, 1995
CEO
Stanley Bergman
Employees
19,000
Stock Exchange
NASDAQ
Ticker Symbol
HSIC
Full Company Profile

Financial Performance

In 2020, Henry Schein's revenue was $10.12 billion, an increase of 1.34% compared to the previous year's $9.99 billion. Earnings were $403.79 million, a decrease of -41.88%.

Financial Statements

Analyst Forecasts

According to 17 analysts, the average rating for Henry Schein stock is "Buy." The 12-month stock price forecast is 74.67, which is an increase of 14.86% from the latest price.

Price Target
$74.67
(14.86% upside)
Analyst Consensus: Buy